RCKT insider files Form 144 to sell 55,684 shares

Rocket Pharmaceuticals files a Form 144 to sell 55,684 shares.

Rhea-AI Filing Summary

Rocket Pharmaceuticals files a Form 144 to sell 55,684 shares. The filing lists an intended sale of 55,684 shares of Common Stock via an option granted on 04/12/2017, with the sale dated 05/21/2026 for cash. The filing also discloses recent transfers: 2,728 shares sold on 05/13/2026 for $9,836.08 and 2,409 shares sold on 05/19/2026 for $7,261.69.

Insights

Securities Compliance Analyst

Form 144 notifies the market of an intended Rule 144 sale of 55,684 shares.

The filing lists a planned cash sale of 55,684 shares tied to an option granted on 04/12/2017. It also records two recent dispositions of 2,728 and 2,409 shares on 05/13/2026 and 05/19/2026.

Timing and exact proceeds for the 55,684 shares are governed by the Rule 144 mechanics and the filing shows the method as cash; subsequent transaction details will appear in public trade reports or other filings.

Corporate Governance Specialist

Multiple small prior dispositions are documented alongside a larger planned sale.

The record shows recorded past transfers totaling 5,137 shares across May 2026, and a larger planned sale of 55,684 shares identified as issuable from an option grant. The filing names a brokerage outlet and lists the sale method as cash.

Investor impact depends on whether the planned shares are sold into the market; the filing itself is a disclosure step under resale rules rather than a market execution report.

Key Figures

Planned sale: 55,684 shares Prior sale 1: 2,728 shares Prior sale 2: 2,409 shares +1 more

4 metrics

Planned sale 55,684 shares sale date <date>05/21/2026</date>, option granted <date>04/12/2017</date>

Prior sale 1 2,728 shares sold on <date>05/13/2026</date> for <money>$9,836.08</money>

Prior sale 2 2,409 shares sold on <date>05/19/2026</date> for <money>$7,261.69</money>

Brokerage listed Fidelity Brokerage Services LLC broker address shown in the filing

Key Terms

Option Granted, Form 144, Rule 144 sale

3 terms

Option Granted financial

"Option Granted - 04/12/2017 is the source of the securities to be sold"

Form 144 regulatory

"The filing header and context identify this as a Form 144 sale notice"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 144 sale regulatory

"Securities To Be Sold and Securities Sold During The Past 3 Months sections reference Rule 144 mechanics"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Rocket Pharmaceuticals' (RCKT) Form 144 disclose?

It discloses an intended cash sale of 55,684 shares tied to an option granted on 04/12/2017. The filing also reports prior sales of 2,728 and 2,409 shares on 05/13/2026 and 05/19/2026.

Who recorded recent share sales in the RCKT filing?

The filing lists Gaurav Shah as having sold 2,728 shares on 05/13/2026 for $9,836.08 and 2,409 shares on 05/19/2026 for $7,261.69. The planned 55,684-share sale is separately identified.

What method is specified for the planned 55,684-share sale?

The planned disposition of 55,684 shares is listed as an issuer transaction tied to an option and the method of sale is specified as cash with the sale date shown as 05/21/2026.

Does the Form 144 show proceeds or pricing for the 55,684 shares?

The filing specifies the sale method as cash and the date 05/21/2026, but it does not state a per-share price or aggregate proceeds for the 55,684 shares within the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 03:40 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001725922
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Shah Gaurav
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	55684	171820.52	109193549	05/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2026	Option Granted - 04/12/2017	Issuer			55684	05/21/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gaurav Shah 9 Cedarbrook Drive Cranbury NJ 08512	Common	05/13/2026	2728	9836.08
Gaurav Shah 9 Cedarbrook Drive Cranbury NJ 08512	Common	05/19/2026	2409	7261.69

144: Remarks and Signature

Remarks
Date of Notice	05/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gaurav Shah
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)